Institute of Human Virology Nigeria

The Institute of Human Virology, Nigeria (IHVN) is a non-governmental organization established in 2004 to address the HIV/AIDS crisis in Nigeria through developing infrastructure for treatment, care, prevention, and support for people living with and those affected with HIV/AIDS. IHVN has now expanded its services to other infectious diseases like tuberculosis and malaria and non- infectious diseases, including cancers.

As a local organization, the Institute is structured to develop and maintain linkages within and outside the country in collaborative ways that support the Government of Nigeria’s health sector strategic plans. IHVN key technical and funding partners include the Centers for Disease Control and Prevention (CDC), the Global Fund to Fight AIDS, Tuberculosis and Malaria and the United States Agency for International Development (USAID).

Projects[]

Action to Control HIV Epidemic through Evidence (ACHIEVE)

The ACHIEVE project implemented by IHVN is funded by the US Government’s PEPFAR (US President’s Emergency Plan for AIDS Relief) through Centers for Disease Control and Prevention (CDC). ACHIEVE focuses on anti-retroviral treatment for adult and children (including pregnant women), prevention of mother-to-child transmission, HIV testing services, support to orphans and vulnerable children, gender-based violence support services & training in all the above areas. As of September 2021, 639,209 patients received care and support for HIV/AIDS, and 524,404 received ARV drugs and treatment under this project.

Global Fund Public Private Mix

IHVN is the first Principal Recipient for the tuberculosis Public Private Mix Scale-up in Nigeria for 2019 and 2020. The grant aims at reducing the tuberculosis burden by scaling up tuberculosis prevention, diagnostic and treatment services through private sector engagement. As at September 2021, 71,477 tuberculosis cases have been notified by non-national TB program providers (in private and non-governmental facilities).

Through the drug-resistant tuberculosis program that IHVN implemented from June 2011 to December 2018, 9,036 bacteriologically confirmed drug-resistant tuberculosis cases were identified, and 6,515 drug-resistant tuberculosis patients enrolled for treatment. IHVN was also a sub-recipient to FHI 360 providing HIV testing, prevention of mother-to-child transmission of HIV, anti-retroviral treatment, and tuberculosis treatment services in ten states in Nigeria.

The Institute also implements The USAID/Nigeria Tuberculosis Local Organization Network (TB-LON 3) project, a five-year project to scale up tuberculosis services and find missing TB cases. It started in April 2020 and is engaging stakeholders in strengthening a resilient system for sustainable TB control in Lagos, Ogun, Oyo and Osun states. As at October 2021, 23,065 tuberculosis cases were identified and notified.

In Sokoto, Zamfara, Niger, Kwara, Kano, Jigawa, Bauchi, Yobe, Borno Adamawa and Kebbi states, IHVN is part of a consortium working with Chemonics, an international development firm, to address HIV by providing HIV prevention, care and treatment services through The Strategic HIV and AIDS Response Program (SHARP) Task Order 1 and 3 USAID funded project.

The Accelerating Nutrition Results in Nigeria (ANRiN) project which IHVN implements in Kano State aims at increasing access and utilization of basic nutrition services for pregnant and lactating women, adolescent girls and children under five years of age. ANRiN is supported by the World Bank (International Development Association and Global Financing Facility). The project commenced in May 2021 in, Nasarawa, Kano Municipal, Fagge, Gwale, Tarauni, Kumbostso, Dala, Bunkure and Wudil Local Government Areas.

Research and Training:

IHVN has established a center, the International Research Center of Excellence (IRCE) to promote public/private partnership for quality health services, capacity building and research in West Africa. IHVN also conducts biomedical research focusing on HIV/AIDS, malaria, tuberculosis and non-communicable diseases, e.g. cancer and diabetes. Funding institutions for these research projects include, US National Institutes of Health (NIH) and Welcome Trust. IHVN builds the capacity of health care providers and ancillary workers across all implementation and research activities. As of September 2021, 47,765 healthcare professionals have been trained in HIV, TB, and other several areas. For more information, visit www.ihvn-irce.org

Funding[]

IHVN is a leading implementer of health projects in Nigeria with funding support from,

US President’s Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention.

Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria.

United States Agency for International Development (USAID).

World Bank (International Development Association and Global Financing Facility) amongst others.

Address[]

Institute of Human Virology, Nigeria

IHVN CAMPUS

Plot 62, Emeritus Umaru Shehu Avenue

Cadastral Zone COO, After Baze University,

Abuja, FCT, Nigeria.

References[]

Website: www.ihvnigeria.org

This Nigeria-related article is a stub. You can help Wikipedia by .

This article about a medical organization or association is a stub. You can help Wikipedia by .